KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Return on Sales (2016 - 2025)

Precigen (PGEN) has disclosed Return on Sales for 14 consecutive years, with 2.99% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 207.0% to 2.99% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 31.61% through Dec 2025, down 508.0% year-over-year, with the annual reading at 25.88% for FY2025, N/A changed from the prior year.
  • Return on Sales for Q4 2025 was 2.99% at Precigen, up from 62.23% in the prior quarter.
  • The five-year high for Return on Sales was 25.22% in Q3 2022, with the low at 23978.0% in Q3 2024.
  • Average Return on Sales over 5 years is 1513.31%, with a median of 0.6% recorded in 2021.
  • Peak annual rise in Return on Sales hit 2391577bps in 2025, while the deepest fall reached -218246bps in 2025.
  • Over 5 years, Return on Sales stood at 0.17% in 2021, then surged by 5326bps to 8.63% in 2022, then surged by 85bps to 15.95% in 2023, then tumbled by -132bps to 5.05% in 2024, then skyrocketed by 41bps to 2.99% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 2.99%, 62.23%, and 649.8% for Q4 2025, Q3 2025, and Q2 2025 respectively.